{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 100,
   "id": "0e56f606-d049-4206-9853-665ddc431b05",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import glob \n",
    "import numpy as np\n",
    "import sqlite3\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "from sklearn.preprocessing import MinMaxScaler\n",
    "from sqlalchemy import create_engine\n",
    "from sklearn.impute import KNNImputer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "fbbe42f9-86c9-4682-a3d3-1864e1a0a3e2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Тип товара</th>\n",
       "      <th>Полное наименование</th>\n",
       "      <th>МНН</th>\n",
       "      <th>Лекарственная форма</th>\n",
       "      <th>Бренд</th>\n",
       "      <th>Фирма-производитель</th>\n",
       "      <th>Корпорация</th>\n",
       "      <th>Фармакотерапевтическая группа</th>\n",
       "      <th>АТС1</th>\n",
       "      <th>АТС2</th>\n",
       "      <th>...</th>\n",
       "      <th>АТС5</th>\n",
       "      <th>Ephmra1</th>\n",
       "      <th>Ephmra2</th>\n",
       "      <th>Ephmra3</th>\n",
       "      <th>Ephmra4</th>\n",
       "      <th>Год</th>\n",
       "      <th>Месяц</th>\n",
       "      <th>Объем (цена розн.-уп.розн.), рубли</th>\n",
       "      <th>Объем (розница), упак.</th>\n",
       "      <th>Объем (цена опт.-уп.розн.), рубли</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018</td>\n",
       "      <td>4</td>\n",
       "      <td>1687765</td>\n",
       "      <td>1466</td>\n",
       "      <td>1461669</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018</td>\n",
       "      <td>11</td>\n",
       "      <td>4113360</td>\n",
       "      <td>3583</td>\n",
       "      <td>3654360</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019</td>\n",
       "      <td>10</td>\n",
       "      <td>5379427</td>\n",
       "      <td>4575</td>\n",
       "      <td>4526456</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>8</td>\n",
       "      <td>4351684</td>\n",
       "      <td>3039</td>\n",
       "      <td>3750294</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>10</td>\n",
       "      <td>3715400</td>\n",
       "      <td>2546</td>\n",
       "      <td>3267094</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3305</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2022</td>\n",
       "      <td>8</td>\n",
       "      <td>16756</td>\n",
       "      <td>6</td>\n",
       "      <td>16756</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3306</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2022</td>\n",
       "      <td>11</td>\n",
       "      <td>124854</td>\n",
       "      <td>64</td>\n",
       "      <td>124854</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3307</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2023</td>\n",
       "      <td>10</td>\n",
       "      <td>10328</td>\n",
       "      <td>8</td>\n",
       "      <td>10328</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3308</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2023</td>\n",
       "      <td>11</td>\n",
       "      <td>2861</td>\n",
       "      <td>4</td>\n",
       "      <td>2861</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3309</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2019</td>\n",
       "      <td>7</td>\n",
       "      <td>1304400</td>\n",
       "      <td>6000</td>\n",
       "      <td>1304400</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3310 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   Тип товара  \\\n",
       "0     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "1     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "2     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "4     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "...                       ...   \n",
       "3305  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3306  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3307  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3308  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3309  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "\n",
       "                                    Полное наименование                  МНН  \\\n",
       "0      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "1      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "2      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "3      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "4      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "...                                                 ...                  ...   \n",
       "3305  ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3306  ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3307  ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3308              ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3309              ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "\n",
       "                                    Лекарственная форма      Бренд  \\\n",
       "0     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "1     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "2     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "3     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "4     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "...                                                 ...        ...   \n",
       "3305  РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...  ЛАЙФФЕРОН   \n",
       "3306  РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...  ЛАЙФФЕРОН   \n",
       "3307  РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...  ЛАЙФФЕРОН   \n",
       "3308               РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  ЛАЙФФЕРОН   \n",
       "3309               РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  ЛАЙФФЕРОН   \n",
       "\n",
       "     Фирма-производитель        Корпорация Фармакотерапевтическая группа  \\\n",
       "0            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "1            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "2            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "3            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "4            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "...                  ...               ...                           ...   \n",
       "3305    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3306    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3307    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3308    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3309    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "\n",
       "                                                   АТС1  \\\n",
       "0     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "1     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "2     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "3     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "4     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "...                                                 ...   \n",
       "3305  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3306  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3307  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3308  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3309  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "\n",
       "                                                   АТС2  ...  \\\n",
       "0     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "1     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "2     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "3     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "4     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "...                                                 ...  ...   \n",
       "3305                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3306                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3307                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3308                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3309                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "\n",
       "                              АТС5  \\\n",
       "0                              NaN   \n",
       "1                              NaN   \n",
       "2                              NaN   \n",
       "3                              NaN   \n",
       "4                              NaN   \n",
       "...                            ...   \n",
       "3305  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3306  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3307  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3308  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3309  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "\n",
       "                                                Ephmra1  \\\n",
       "0     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "1     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "2     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "3     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "4     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "...                                                 ...   \n",
       "3305  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3306  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3307  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3308  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3309  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "\n",
       "                                                Ephmra2  \\\n",
       "0     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "1     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "2     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "3     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "4     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "...                                                 ...   \n",
       "3305                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3306                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3307                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3308                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3309                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "\n",
       "                                            Ephmra3  \\\n",
       "0     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "1     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "2     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "3     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "4     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "...                                             ...   \n",
       "3305                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3306                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3307                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3308                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3309                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "\n",
       "                         Ephmra4   Год Месяц  \\\n",
       "0                            NaN  2018     4   \n",
       "1                            NaN  2018    11   \n",
       "2                            NaN  2019    10   \n",
       "3                            NaN  2020     8   \n",
       "4                            NaN  2020    10   \n",
       "...                          ...   ...   ...   \n",
       "3305  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2022     8   \n",
       "3306  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2022    11   \n",
       "3307  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2023    10   \n",
       "3308  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2023    11   \n",
       "3309  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2019     7   \n",
       "\n",
       "      Объем (цена розн.-уп.розн.), рубли  Объем (розница), упак.  \\\n",
       "0                                1687765                    1466   \n",
       "1                                4113360                    3583   \n",
       "2                                5379427                    4575   \n",
       "3                                4351684                    3039   \n",
       "4                                3715400                    2546   \n",
       "...                                  ...                     ...   \n",
       "3305                               16756                       6   \n",
       "3306                              124854                      64   \n",
       "3307                               10328                       8   \n",
       "3308                                2861                       4   \n",
       "3309                             1304400                    6000   \n",
       "\n",
       "      Объем (цена опт.-уп.розн.), рубли  \n",
       "0                               1461669  \n",
       "1                               3654360  \n",
       "2                               4526456  \n",
       "3                               3750294  \n",
       "4                               3267094  \n",
       "...                                 ...  \n",
       "3305                              16756  \n",
       "3306                             124854  \n",
       "3307                              10328  \n",
       "3308                               2861  \n",
       "3309                            1304400  \n",
       "\n",
       "[3310 rows x 22 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_excel('Desktop/Новая папка/Рассеянный склероз_ДСМ.xlsx') \n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "a41f7655-cd2f-4b23-8bf9-90b94f0c8ce8",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Подключиться к базе данных SQLite\n",
    "conn = sqlite3.connect('Desktop/Новая папка/database.sqlite3')\n",
    "c = conn.cursor()\n",
    "\n",
    "# Создать таблицу для хранения данных Excel\n",
    "c.execute( '''CREATE TABLE IF NOT EXISTS analytics(\n",
    "      id INTEGER PRIMARY KEY AUTOINCREMENT,\n",
    "      Тип товара TEXT,\n",
    "      Полное наименование TEXT,\n",
    "      МНН TEXT,\n",
    "      Лекарственная форма TEXT,\n",
    "      Бренд TEXT,\n",
    "      Фирма_производитель TEXT,\n",
    "      Корпорация TEXT,\n",
    "      Фармакотерапевтическая группа TEXT,\n",
    "      АТС1 TEXT,\n",
    "      АТС2 TEXT,\n",
    "      АТС3 TEXT,\n",
    "      АТС4 TEXT,\n",
    "      АТС5 TEXT,\n",
    "      Ephmra1 TEXT,\n",
    "      Ephmra2 TEXT,\n",
    "      Ephmra3 TEXT,\n",
    "      Ephmra4 TEXT,\n",
    "      Год INTEGER,\n",
    "      Месяц INTEGER,\n",
    "      Объем1 INTEGER,\n",
    "      Объем2 INTEGER,\n",
    "      Объем3 INTEGER)''')\n",
    "\n",
    "# Вставить данные из DataFrame в таблицу\n",
    "df.to_sql('analytics', conn, if_exists='replace', index=True)\n",
    "\n",
    "# Зафиксировать изменения \n",
    "conn.commit()\n",
    "conn.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "71a57482-fc25-4fba-80a7-5d6de35d9ec5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Тип товара</th>\n",
       "      <th>Полное наименование</th>\n",
       "      <th>МНН</th>\n",
       "      <th>Лекарственная форма</th>\n",
       "      <th>Бренд</th>\n",
       "      <th>Фирма-производитель</th>\n",
       "      <th>Корпорация</th>\n",
       "      <th>Фармакотерапевтическая группа</th>\n",
       "      <th>АТС1</th>\n",
       "      <th>АТС2</th>\n",
       "      <th>...</th>\n",
       "      <th>АТС5</th>\n",
       "      <th>Ephmra1</th>\n",
       "      <th>Ephmra2</th>\n",
       "      <th>Ephmra3</th>\n",
       "      <th>Ephmra4</th>\n",
       "      <th>Год</th>\n",
       "      <th>Месяц</th>\n",
       "      <th>Объем (цена розн.-уп.розн.), рубли</th>\n",
       "      <th>Объем (розница), упак.</th>\n",
       "      <th>Объем (цена опт.-уп.розн.), рубли</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018</td>\n",
       "      <td>4</td>\n",
       "      <td>1687765</td>\n",
       "      <td>1466</td>\n",
       "      <td>1461669</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018</td>\n",
       "      <td>11</td>\n",
       "      <td>4113360</td>\n",
       "      <td>3583</td>\n",
       "      <td>3654360</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019</td>\n",
       "      <td>10</td>\n",
       "      <td>5379427</td>\n",
       "      <td>4575</td>\n",
       "      <td>4526456</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>8</td>\n",
       "      <td>4351684</td>\n",
       "      <td>3039</td>\n",
       "      <td>3750294</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>10</td>\n",
       "      <td>3715400</td>\n",
       "      <td>2546</td>\n",
       "      <td>3267094</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3305</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2022</td>\n",
       "      <td>8</td>\n",
       "      <td>16756</td>\n",
       "      <td>6</td>\n",
       "      <td>16756</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3306</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2022</td>\n",
       "      <td>11</td>\n",
       "      <td>124854</td>\n",
       "      <td>64</td>\n",
       "      <td>124854</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3307</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2023</td>\n",
       "      <td>10</td>\n",
       "      <td>10328</td>\n",
       "      <td>8</td>\n",
       "      <td>10328</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3308</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2023</td>\n",
       "      <td>11</td>\n",
       "      <td>2861</td>\n",
       "      <td>4</td>\n",
       "      <td>2861</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3309</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2019</td>\n",
       "      <td>7</td>\n",
       "      <td>1304400</td>\n",
       "      <td>6000</td>\n",
       "      <td>1304400</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3310 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   Тип товара  \\\n",
       "0     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "1     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "2     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "4     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "...                       ...   \n",
       "3305  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3306  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3307  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3308  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3309  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "\n",
       "                                    Полное наименование                  МНН  \\\n",
       "0      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "1      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "2      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "3      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "4      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "...                                                 ...                  ...   \n",
       "3305  ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3306  ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3307  ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3308              ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3309              ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "\n",
       "                                    Лекарственная форма      Бренд  \\\n",
       "0     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "1     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "2     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "3     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "4     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "...                                                 ...        ...   \n",
       "3305  РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...  ЛАЙФФЕРОН   \n",
       "3306  РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...  ЛАЙФФЕРОН   \n",
       "3307  РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...  ЛАЙФФЕРОН   \n",
       "3308               РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  ЛАЙФФЕРОН   \n",
       "3309               РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  ЛАЙФФЕРОН   \n",
       "\n",
       "     Фирма-производитель        Корпорация Фармакотерапевтическая группа  \\\n",
       "0            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "1            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "2            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "3            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "4            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "...                  ...               ...                           ...   \n",
       "3305    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3306    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3307    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3308    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3309    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "\n",
       "                                                   АТС1  \\\n",
       "0     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "1     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "2     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "3     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "4     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "...                                                 ...   \n",
       "3305  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3306  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3307  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3308  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3309  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "\n",
       "                                                   АТС2  ...  \\\n",
       "0     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "1     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "2     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "3     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "4     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "...                                                 ...  ...   \n",
       "3305                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3306                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3307                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3308                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3309                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "\n",
       "                              АТС5  \\\n",
       "0                              NaN   \n",
       "1                              NaN   \n",
       "2                              NaN   \n",
       "3                              NaN   \n",
       "4                              NaN   \n",
       "...                            ...   \n",
       "3305  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3306  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3307  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3308  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3309  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "\n",
       "                                                Ephmra1  \\\n",
       "0     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "1     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "2     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "3     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "4     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "...                                                 ...   \n",
       "3305  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3306  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3307  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3308  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3309  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "\n",
       "                                                Ephmra2  \\\n",
       "0     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "1     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "2     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "3     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "4     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "...                                                 ...   \n",
       "3305                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3306                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3307                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3308                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3309                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "\n",
       "                                            Ephmra3  \\\n",
       "0     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "1     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "2     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "3     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "4     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "...                                             ...   \n",
       "3305                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3306                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3307                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3308                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3309                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "\n",
       "                         Ephmra4   Год Месяц  \\\n",
       "0                            NaN  2018     4   \n",
       "1                            NaN  2018    11   \n",
       "2                            NaN  2019    10   \n",
       "3                            NaN  2020     8   \n",
       "4                            NaN  2020    10   \n",
       "...                          ...   ...   ...   \n",
       "3305  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2022     8   \n",
       "3306  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2022    11   \n",
       "3307  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2023    10   \n",
       "3308  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2023    11   \n",
       "3309  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2019     7   \n",
       "\n",
       "      Объем (цена розн.-уп.розн.), рубли  Объем (розница), упак.  \\\n",
       "0                                1687765                    1466   \n",
       "1                                4113360                    3583   \n",
       "2                                5379427                    4575   \n",
       "3                                4351684                    3039   \n",
       "4                                3715400                    2546   \n",
       "...                                  ...                     ...   \n",
       "3305                               16756                       6   \n",
       "3306                              124854                      64   \n",
       "3307                               10328                       8   \n",
       "3308                                2861                       4   \n",
       "3309                             1304400                    6000   \n",
       "\n",
       "      Объем (цена опт.-уп.розн.), рубли  \n",
       "0                               1461669  \n",
       "1                               3654360  \n",
       "2                               4526456  \n",
       "3                               3750294  \n",
       "4                               3267094  \n",
       "...                                 ...  \n",
       "3305                              16756  \n",
       "3306                             124854  \n",
       "3307                              10328  \n",
       "3308                               2861  \n",
       "3309                            1304400  \n",
       "\n",
       "[3310 rows x 22 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Профилирование данных\n",
    "df = pd.read_excel('Desktop/Новая папка/Рассеянный склероз_ДСМ.xlsx')\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "d33d79c3-d0b0-4a52-8e49-5ad4343aff37",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 3310 entries, 0 to 3309\n",
      "Data columns (total 22 columns):\n",
      " #   Column                              Non-Null Count  Dtype \n",
      "---  ------                              --------------  ----- \n",
      " 0   Тип товара                          3310 non-null   object\n",
      " 1   Полное наименование                 3310 non-null   object\n",
      " 2   МНН                                 3310 non-null   object\n",
      " 3   Лекарственная форма                 3310 non-null   object\n",
      " 4   Бренд                               3310 non-null   object\n",
      " 5   Фирма-производитель                 3310 non-null   object\n",
      " 6   Корпорация                          3310 non-null   object\n",
      " 7   Фармакотерапевтическая группа       3310 non-null   object\n",
      " 8   АТС1                                3310 non-null   object\n",
      " 9   АТС2                                3236 non-null   object\n",
      " 10  АТС3                                3236 non-null   object\n",
      " 11  АТС4                                3080 non-null   object\n",
      " 12  АТС5                                2936 non-null   object\n",
      " 13  Ephmra1                             3310 non-null   object\n",
      " 14  Ephmra2                             3310 non-null   object\n",
      " 15  Ephmra3                             3310 non-null   object\n",
      " 16  Ephmra4                             2474 non-null   object\n",
      " 17  Год                                 3310 non-null   int64 \n",
      " 18  Месяц                               3310 non-null   int64 \n",
      " 19  Объем (цена розн.-уп.розн.), рубли  3310 non-null   int64 \n",
      " 20  Объем (розница), упак.              3310 non-null   int64 \n",
      " 21  Объем (цена опт.-уп.розн.), рубли   3310 non-null   int64 \n",
      "dtypes: int64(5), object(17)\n",
      "memory usage: 569.0+ KB\n"
     ]
    }
   ],
   "source": [
    "#Проверяем данные\n",
    "df.info('Desktop/Новая папка/Рассеянный склероз_ДСМ.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "b17a1596-a9a8-47ac-bcab-1afbdf7a57fe",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Тип товара</th>\n",
       "      <th>Полное наименование</th>\n",
       "      <th>МНН</th>\n",
       "      <th>Лекарственная форма</th>\n",
       "      <th>Бренд</th>\n",
       "      <th>Фирма_производитель</th>\n",
       "      <th>Корпорация</th>\n",
       "      <th>Фармакотерапевтическая группа</th>\n",
       "      <th>АТС1</th>\n",
       "      <th>АТС2</th>\n",
       "      <th>...</th>\n",
       "      <th>АТС5</th>\n",
       "      <th>Ephmra1</th>\n",
       "      <th>Ephmra2</th>\n",
       "      <th>Ephmra3</th>\n",
       "      <th>Ephmra4</th>\n",
       "      <th>Год</th>\n",
       "      <th>Месяц</th>\n",
       "      <th>Объем1</th>\n",
       "      <th>Объем2</th>\n",
       "      <th>Объем3</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018</td>\n",
       "      <td>4</td>\n",
       "      <td>1687765</td>\n",
       "      <td>1466</td>\n",
       "      <td>1461669</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018</td>\n",
       "      <td>11</td>\n",
       "      <td>4113360</td>\n",
       "      <td>3583</td>\n",
       "      <td>3654360</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019</td>\n",
       "      <td>10</td>\n",
       "      <td>5379427</td>\n",
       "      <td>4575</td>\n",
       "      <td>4526456</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>8</td>\n",
       "      <td>4351684</td>\n",
       "      <td>3039</td>\n",
       "      <td>3750294</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ИПИДАКРИН</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ИПИГРИКС</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>GRINDEKS AS</td>\n",
       "      <td>ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...</td>\n",
       "      <td>ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...</td>\n",
       "      <td>ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>10</td>\n",
       "      <td>3715400</td>\n",
       "      <td>2546</td>\n",
       "      <td>3267094</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3305</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2022</td>\n",
       "      <td>8</td>\n",
       "      <td>16756</td>\n",
       "      <td>6</td>\n",
       "      <td>16756</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3306</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2022</td>\n",
       "      <td>11</td>\n",
       "      <td>124854</td>\n",
       "      <td>64</td>\n",
       "      <td>124854</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3307</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2023</td>\n",
       "      <td>10</td>\n",
       "      <td>10328</td>\n",
       "      <td>8</td>\n",
       "      <td>10328</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3308</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2023</td>\n",
       "      <td>11</td>\n",
       "      <td>2861</td>\n",
       "      <td>4</td>\n",
       "      <td>2861</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3309</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА-2B</td>\n",
       "      <td>РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ЛАЙФФЕРОН</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ВЕКТОР-МЕДИКА АО</td>\n",
       "      <td>ЦИТОКИН</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ИНТЕРФЕРОН АЛЬФА2B (L03AB05)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ (L03B)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)</td>\n",
       "      <td>2019</td>\n",
       "      <td>7</td>\n",
       "      <td>1304400</td>\n",
       "      <td>6000</td>\n",
       "      <td>1304400</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3310 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   Тип товара  \\\n",
       "0     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "1     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "2     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "4     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "...                       ...   \n",
       "3305  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3306  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3307  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3308  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3309  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "\n",
       "                                    Полное наименование                  МНН  \\\n",
       "0      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "1      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "2      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "3      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "4      ИПИГРИКС РАСТ Д/В/М И П/К ВВЕД 15 МГ/МЛ 1 МЛ №10            ИПИДАКРИН   \n",
       "...                                                 ...                  ...   \n",
       "3305  ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3306  ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3307  ЛАЙФФЕРОН РАСТ Д/В/М СУБКОНЪЮНКТ ВВЕД И ЗАКАП ...  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3308              ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "3309              ЛАЙФФЕРОН РАСТ Д/В/М ВВЕД 1 МЛН.МЕ №1  ИНТЕРФЕРОН АЛЬФА-2B   \n",
       "\n",
       "                                    Лекарственная форма      Бренд  \\\n",
       "0     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "1     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "2     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "3     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "4     РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ   ИПИГРИКС   \n",
       "...                                                 ...        ...   \n",
       "3305  РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...  ЛАЙФФЕРОН   \n",
       "3306  РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...  ЛАЙФФЕРОН   \n",
       "3307  РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО СУБКОНЪЮНКТИВАЛЬНО...  ЛАЙФФЕРОН   \n",
       "3308               РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  ЛАЙФФЕРОН   \n",
       "3309               РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  ЛАЙФФЕРОН   \n",
       "\n",
       "     Фирма_производитель        Корпорация Фармакотерапевтическая группа  \\\n",
       "0            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "1            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "2            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "3            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "4            GRINDEKS AS       GRINDEKS AS       ХОЛИНЭСТЕРАЗЫ ИНГИБИТОР   \n",
       "...                  ...               ...                           ...   \n",
       "3305    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3306    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3307    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3308    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "3309    ВЕКТОР-МЕДИКА АО  ВЕКТОР-МЕДИКА АО                       ЦИТОКИН   \n",
       "\n",
       "                                                   АТС1  \\\n",
       "0     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "1     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "2     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "3     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "4     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "...                                                 ...   \n",
       "3305  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3306  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3307  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3308  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3309  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "\n",
       "                                                   АТС2  ...  \\\n",
       "0     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "1     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "2     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "3     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "4     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...  ...   \n",
       "...                                                 ...  ...   \n",
       "3305                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3306                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3307                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3308                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "3309                             ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "\n",
       "                              АТС5  \\\n",
       "0                              NaN   \n",
       "1                              NaN   \n",
       "2                              NaN   \n",
       "3                              NaN   \n",
       "4                              NaN   \n",
       "...                            ...   \n",
       "3305  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3306  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3307  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3308  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "3309  ИНТЕРФЕРОН АЛЬФА2B (L03AB05)   \n",
       "\n",
       "                                                Ephmra1  \\\n",
       "0     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "1     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "2     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "3     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "4     ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ НЕРВНОЙ СИСТ...   \n",
       "...                                                 ...   \n",
       "3305  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3306  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3307  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3308  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3309  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "\n",
       "                                                Ephmra2  \\\n",
       "0     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "1     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "2     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "3     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "4     ПРОЧИЕ ПРЕПАРАТЫ ПРИМЕНЯЕМЫ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕ...   \n",
       "...                                                 ...   \n",
       "3305                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3306                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3307                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3308                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "3309                            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "\n",
       "                                            Ephmra3  \\\n",
       "0     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "1     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "2     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "3     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "4     ПРОЧИЕ СРЕДСТВА ПРОТИВ ЗАБОЛЕВАНИЙ ЦНС (N07X)   \n",
       "...                                             ...   \n",
       "3305                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3306                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3307                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3308                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "3309                             ИНТЕРФЕРОНЫ (L03B)   \n",
       "\n",
       "                         Ephmra4   Год Месяц   Объем1  Объем2   Объем3  \n",
       "0                            NaN  2018     4  1687765    1466  1461669  \n",
       "1                            NaN  2018    11  4113360    3583  3654360  \n",
       "2                            NaN  2019    10  5379427    4575  4526456  \n",
       "3                            NaN  2020     8  4351684    3039  3750294  \n",
       "4                            NaN  2020    10  3715400    2546  3267094  \n",
       "...                          ...   ...   ...      ...     ...      ...  \n",
       "3305  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2022     8    16756       6    16756  \n",
       "3306  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2022    11   124854      64   124854  \n",
       "3307  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2023    10    10328       8    10328  \n",
       "3308  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2023    11     2861       4     2861  \n",
       "3309  ИНТЕРФЕРОНЫ, АЛЬФА (L03B1)  2019     7  1304400    6000  1304400  \n",
       "\n",
       "[3310 rows x 22 columns]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Переименуем столбцы Объема как в бз для облегчения визиулизации и исключения дальнейших ошибок\n",
    "df = df.rename(columns={'Объем (цена розн.-уп.розн.), рубли': 'Объем1', 'Объем (розница), упак.': 'Объем2', 'Объем (цена опт.-уп.розн.), рубли': 'Объем3', 'Фирма-производитель': 'Фирма_производитель'})\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "524a7f0b-95e2-409d-a516-6d129d595d60",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Тип товара</th>\n",
       "      <th>Полное наименование</th>\n",
       "      <th>МНН</th>\n",
       "      <th>Лекарственная форма</th>\n",
       "      <th>Бренд</th>\n",
       "      <th>Фирма_производитель</th>\n",
       "      <th>Корпорация</th>\n",
       "      <th>Фармакотерапевтическая группа</th>\n",
       "      <th>АТС1</th>\n",
       "      <th>АТС2</th>\n",
       "      <th>...</th>\n",
       "      <th>АТС5</th>\n",
       "      <th>Ephmra1</th>\n",
       "      <th>Ephmra2</th>\n",
       "      <th>Ephmra3</th>\n",
       "      <th>Ephmra4</th>\n",
       "      <th>Год</th>\n",
       "      <th>Месяц</th>\n",
       "      <th>Объем1</th>\n",
       "      <th>Объем2</th>\n",
       "      <th>Объем3</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>АЛЕМТУЗУМАБ (L04AA34)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021</td>\n",
       "      <td>12</td>\n",
       "      <td>174317593</td>\n",
       "      <td>470</td>\n",
       "      <td>174317593</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>АЛЕМТУЗУМАБ (L04AA34)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>8</td>\n",
       "      <td>18729715</td>\n",
       "      <td>50</td>\n",
       "      <td>18729715</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>АЛЕМТУЗУМАБ (L04AA34)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019</td>\n",
       "      <td>9</td>\n",
       "      <td>24879249</td>\n",
       "      <td>50</td>\n",
       "      <td>24879249</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>АЛЕМТУЗУМАБ (L04AA34)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018</td>\n",
       "      <td>12</td>\n",
       "      <td>31115786</td>\n",
       "      <td>104</td>\n",
       "      <td>31115786</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>АЛЕМТУЗУМАБ (L04AA34)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023</td>\n",
       "      <td>7</td>\n",
       "      <td>84412416</td>\n",
       "      <td>315</td>\n",
       "      <td>84412416</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3305</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ТЕТРАКОЗАКТИД</td>\n",
       "      <td>СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>СИНАКТЕН</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>АКТГ</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...</td>\n",
       "      <td>...</td>\n",
       "      <td>ТЕТРАКОЗАКТИД (H01AA02)</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)</td>\n",
       "      <td>КОРТИКОТРОПИН (H01A)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021</td>\n",
       "      <td>12</td>\n",
       "      <td>710</td>\n",
       "      <td>1</td>\n",
       "      <td>478</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3306</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ТЕТРАКОЗАКТИД</td>\n",
       "      <td>СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>СИНАКТЕН</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>АКТГ</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...</td>\n",
       "      <td>...</td>\n",
       "      <td>ТЕТРАКОЗАКТИД (H01AA02)</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)</td>\n",
       "      <td>КОРТИКОТРОПИН (H01A)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019</td>\n",
       "      <td>8</td>\n",
       "      <td>19383</td>\n",
       "      <td>32</td>\n",
       "      <td>15412</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3307</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ТЕТРАКОЗАКТИД</td>\n",
       "      <td>СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>СИНАКТЕН</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>АКТГ</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...</td>\n",
       "      <td>...</td>\n",
       "      <td>ТЕТРАКОЗАКТИД (H01AA02)</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)</td>\n",
       "      <td>КОРТИКОТРОПИН (H01A)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019</td>\n",
       "      <td>5</td>\n",
       "      <td>14686</td>\n",
       "      <td>30</td>\n",
       "      <td>12969</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3308</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ТЕТРАКОЗАКТИД</td>\n",
       "      <td>СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>СИНАКТЕН</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>АКТГ</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...</td>\n",
       "      <td>...</td>\n",
       "      <td>ТЕТРАКОЗАКТИД (H01AA02)</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)</td>\n",
       "      <td>КОРТИКОТРОПИН (H01A)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023</td>\n",
       "      <td>8</td>\n",
       "      <td>40700</td>\n",
       "      <td>20</td>\n",
       "      <td>40700</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3309</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ТЕТРАКОЗАКТИД</td>\n",
       "      <td>СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>СИНАКТЕН</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>АКТГ</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...</td>\n",
       "      <td>...</td>\n",
       "      <td>ТЕТРАКОЗАКТИД (H01AA02)</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)</td>\n",
       "      <td>КОРТИКОТРОПИН (H01A)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019</td>\n",
       "      <td>7</td>\n",
       "      <td>31310</td>\n",
       "      <td>65</td>\n",
       "      <td>25882</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3310 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   Тип товара  \\\n",
       "0     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "1     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "2     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "4     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "...                       ...   \n",
       "3305  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3306  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3307  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3308  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3309  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "\n",
       "                                    Полное наименование            МНН  \\\n",
       "0     ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...    АЛЕМТУЗУМАБ   \n",
       "1     ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...    АЛЕМТУЗУМАБ   \n",
       "2     ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...    АЛЕМТУЗУМАБ   \n",
       "3     ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...    АЛЕМТУЗУМАБ   \n",
       "4     ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...    АЛЕМТУЗУМАБ   \n",
       "...                                                 ...            ...   \n",
       "3305     СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10  ТЕТРАКОЗАКТИД   \n",
       "3306     СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10  ТЕТРАКОЗАКТИД   \n",
       "3307     СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10  ТЕТРАКОЗАКТИД   \n",
       "3308     СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10  ТЕТРАКОЗАКТИД   \n",
       "3309     СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10  ТЕТРАКОЗАКТИД   \n",
       "\n",
       "                                    Лекарственная форма     Бренд  \\\n",
       "0     КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "1     КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "2     КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "3     КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "4     КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "...                                                 ...       ...   \n",
       "3305             СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  СИНАКТЕН   \n",
       "3306             СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  СИНАКТЕН   \n",
       "3307             СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  СИНАКТЕН   \n",
       "3308             СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  СИНАКТЕН   \n",
       "3309             СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  СИНАКТЕН   \n",
       "\n",
       "            Фирма_производитель                 Корпорация  \\\n",
       "0           GENZYME CORPORATION                  SANOFI SA   \n",
       "1           GENZYME CORPORATION                  SANOFI SA   \n",
       "2           GENZYME CORPORATION                  SANOFI SA   \n",
       "3           GENZYME CORPORATION                  SANOFI SA   \n",
       "4           GENZYME CORPORATION                  SANOFI SA   \n",
       "...                         ...                        ...   \n",
       "3305  NOVARTIS INTERNATIONAL AG  NOVARTIS INTERNATIONAL AG   \n",
       "3306  NOVARTIS INTERNATIONAL AG  NOVARTIS INTERNATIONAL AG   \n",
       "3307  NOVARTIS INTERNATIONAL AG  NOVARTIS INTERNATIONAL AG   \n",
       "3308  NOVARTIS INTERNATIONAL AG  NOVARTIS INTERNATIONAL AG   \n",
       "3309  NOVARTIS INTERNATIONAL AG  NOVARTIS INTERNATIONAL AG   \n",
       "\n",
       "     Фармакотерапевтическая группа  \\\n",
       "0     СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "1     СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "2     СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "3     СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "4     СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "...                            ...   \n",
       "3305                          АКТГ   \n",
       "3306                          АКТГ   \n",
       "3307                          АКТГ   \n",
       "3308                          АКТГ   \n",
       "3309                          АКТГ   \n",
       "\n",
       "                                                   АТС1  \\\n",
       "0     ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "1     ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "2     ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3     ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "4     ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "...                                                 ...   \n",
       "3305  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3306  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3307  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3308  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3309  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "\n",
       "                                                   АТС2  ...  \\\n",
       "0                               ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "1                               ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "2                               ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "3                               ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "4                               ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "...                                                 ...  ...   \n",
       "3305  ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...  ...   \n",
       "3306  ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...  ...   \n",
       "3307  ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...  ...   \n",
       "3308  ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...  ...   \n",
       "3309  ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...  ...   \n",
       "\n",
       "                         АТС5  \\\n",
       "0       АЛЕМТУЗУМАБ (L04AA34)   \n",
       "1       АЛЕМТУЗУМАБ (L04AA34)   \n",
       "2       АЛЕМТУЗУМАБ (L04AA34)   \n",
       "3       АЛЕМТУЗУМАБ (L04AA34)   \n",
       "4       АЛЕМТУЗУМАБ (L04AA34)   \n",
       "...                       ...   \n",
       "3305  ТЕТРАКОЗАКТИД (H01AA02)   \n",
       "3306  ТЕТРАКОЗАКТИД (H01AA02)   \n",
       "3307  ТЕТРАКОЗАКТИД (H01AA02)   \n",
       "3308  ТЕТРАКОЗАКТИД (H01AA02)   \n",
       "3309  ТЕТРАКОЗАКТИД (H01AA02)   \n",
       "\n",
       "                                                Ephmra1  \\\n",
       "0     ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "1     ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "2     ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3     ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "4     ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "...                                                 ...   \n",
       "3305  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3306  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3307  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3308  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3309  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "\n",
       "                                    Ephmra2  \\\n",
       "0         ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "1         ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "2         ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "3         ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "4         ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "...                                     ...   \n",
       "3305  ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)   \n",
       "3306  ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)   \n",
       "3307  ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)   \n",
       "3308  ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)   \n",
       "3309  ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)   \n",
       "\n",
       "                                               Ephmra3 Ephmra4   Год Месяц  \\\n",
       "0     МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)     NaN  2021    12   \n",
       "1     МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)     NaN  2020     8   \n",
       "2     МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)     NaN  2019     9   \n",
       "3     МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)     NaN  2018    12   \n",
       "4     МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)     NaN  2023     7   \n",
       "...                                                ...     ...   ...   ...   \n",
       "3305                              КОРТИКОТРОПИН (H01A)     NaN  2021    12   \n",
       "3306                              КОРТИКОТРОПИН (H01A)     NaN  2019     8   \n",
       "3307                              КОРТИКОТРОПИН (H01A)     NaN  2019     5   \n",
       "3308                              КОРТИКОТРОПИН (H01A)     NaN  2023     8   \n",
       "3309                              КОРТИКОТРОПИН (H01A)     NaN  2019     7   \n",
       "\n",
       "         Объем1  Объем2     Объем3  \n",
       "0     174317593     470  174317593  \n",
       "1      18729715      50   18729715  \n",
       "2      24879249      50   24879249  \n",
       "3      31115786     104   31115786  \n",
       "4      84412416     315   84412416  \n",
       "...         ...     ...        ...  \n",
       "3305        710       1        478  \n",
       "3306      19383      32      15412  \n",
       "3307      14686      30      12969  \n",
       "3308      40700      20      40700  \n",
       "3309      31310      65      25882  \n",
       "\n",
       "[3310 rows x 22 columns]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#отсортируем МНН по алфавиту и индексу\n",
    "df.sort_values(by=['МНН'], inplace=True)\n",
    "df.index = np.arange(0,3310)\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "13dfdd27-2dc0-4441-bd92-87e3a81a4cfc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Год</th>\n",
       "      <th>Месяц</th>\n",
       "      <th>Объем1</th>\n",
       "      <th>Объем2</th>\n",
       "      <th>Объем3</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>3310.000000</td>\n",
       "      <td>3310.000000</td>\n",
       "      <td>3.310000e+03</td>\n",
       "      <td>3310.000000</td>\n",
       "      <td>3.310000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>2020.313595</td>\n",
       "      <td>6.508459</td>\n",
       "      <td>2.718105e+07</td>\n",
       "      <td>3963.311480</td>\n",
       "      <td>2.694675e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>1.699954</td>\n",
       "      <td>3.431815</td>\n",
       "      <td>1.581889e+08</td>\n",
       "      <td>20371.195158</td>\n",
       "      <td>1.582048e+08</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>2018.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>5.000000e+00</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>3.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>2019.000000</td>\n",
       "      <td>4.000000</td>\n",
       "      <td>7.671525e+04</td>\n",
       "      <td>32.000000</td>\n",
       "      <td>7.149850e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>2020.000000</td>\n",
       "      <td>7.000000</td>\n",
       "      <td>7.219500e+05</td>\n",
       "      <td>278.000000</td>\n",
       "      <td>6.845090e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>2022.000000</td>\n",
       "      <td>9.000000</td>\n",
       "      <td>4.787541e+06</td>\n",
       "      <td>2383.250000</td>\n",
       "      <td>4.327364e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>2023.000000</td>\n",
       "      <td>12.000000</td>\n",
       "      <td>3.353175e+09</td>\n",
       "      <td>594366.000000</td>\n",
       "      <td>3.353175e+09</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "               Год        Месяц        Объем1         Объем2        Объем3\n",
       "count  3310.000000  3310.000000  3.310000e+03    3310.000000  3.310000e+03\n",
       "mean   2020.313595     6.508459  2.718105e+07    3963.311480  2.694675e+07\n",
       "std       1.699954     3.431815  1.581889e+08   20371.195158  1.582048e+08\n",
       "min    2018.000000     1.000000  5.000000e+00       1.000000  3.000000e+00\n",
       "25%    2019.000000     4.000000  7.671525e+04      32.000000  7.149850e+04\n",
       "50%    2020.000000     7.000000  7.219500e+05     278.000000  6.845090e+05\n",
       "75%    2022.000000     9.000000  4.787541e+06    2383.250000  4.327364e+06\n",
       "max    2023.000000    12.000000  3.353175e+09  594366.000000  3.353175e+09"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# посмотрим на разброс данных\n",
    "df.describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "45e6338d-6141-4b01-bc91-448181335b8c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Объем2\n",
       "2        90\n",
       "1        79\n",
       "6        56\n",
       "4        54\n",
       "3        50\n",
       "         ..\n",
       "12061     1\n",
       "14164     1\n",
       "6832      1\n",
       "6033      1\n",
       "850       1\n",
       "Name: count, Length: 1680, dtype: int64"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Отрицательных значений не наблюдается.\n",
    "#так как в дальнейшем планируем работать со столбцом отражающий количество проданных в розницу лекарственных средств выраженных в упаковках, то посмотрим на количество МНН, у которых менее 1000 продаж\n",
    "\n",
    "df['Объем2'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "ac56bae9-be3e-47c4-b4cd-5ece70f4b99d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Объем2\n",
       "3101     3\n",
       "1084     3\n",
       "1116     3\n",
       "1451     2\n",
       "2428     2\n",
       "        ..\n",
       "1082     1\n",
       "2949     1\n",
       "1101     1\n",
       "2155     1\n",
       "13097    1\n",
       "Name: count, Length: 1069, dtype: int64"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1 = df[df['Объем2'] >= 1000]\n",
    "df1['Объем2'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "374d3516-e70c-4f1e-85b9-adacb8d858c8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.duplicated().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "9b408b60-7093-47ec-b7e2-7bcc4843eaac",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Тип товара</th>\n",
       "      <th>Полное наименование</th>\n",
       "      <th>МНН</th>\n",
       "      <th>Лекарственная форма</th>\n",
       "      <th>Бренд</th>\n",
       "      <th>Фирма_производитель</th>\n",
       "      <th>Корпорация</th>\n",
       "      <th>Фармакотерапевтическая группа</th>\n",
       "      <th>АТС1</th>\n",
       "      <th>АТС2</th>\n",
       "      <th>...</th>\n",
       "      <th>АТС5</th>\n",
       "      <th>Ephmra1</th>\n",
       "      <th>Ephmra2</th>\n",
       "      <th>Ephmra3</th>\n",
       "      <th>Ephmra4</th>\n",
       "      <th>Год</th>\n",
       "      <th>Месяц</th>\n",
       "      <th>Объем1</th>\n",
       "      <th>Объем2</th>\n",
       "      <th>Объем3</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>0 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [Тип товара, Полное наименование, МНН, Лекарственная форма, Бренд, Фирма_производитель, Корпорация, Фармакотерапевтическая группа, АТС1, АТС2, АТС3, АТС4, АТС5, Ephmra1, Ephmra2, Ephmra3, Ephmra4, Год, Месяц, Объем1, Объем2, Объем3]\n",
       "Index: []\n",
       "\n",
       "[0 rows x 22 columns]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Дубликатов нет\n",
    "#Работа с пропусками при просмотре разбраса данных можно убедиться, что отрицательных или пустых числовых значений нет.\n",
    "# проверяем на наличие пропусков в столбцах по Объемам\n",
    "filtered_df = df1[(df1['Объем1'] < 1) & (df1['Объем2'] < 1)& (df1['Объем3'] < 1)]\n",
    "filtered_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b96fd669-4b50-41bb-8a69-62d77aad7532",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Проверка подтвердила, что пропусков нет в числовых значениях"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "ff198aa8-330c-41c4-a5d8-b7a635685b2c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Тип товара                         0\n",
       "Полное наименование                0\n",
       "МНН                                0\n",
       "Лекарственная форма                0\n",
       "Бренд                              0\n",
       "Фирма_производитель                0\n",
       "Корпорация                         0\n",
       "Фармакотерапевтическая группа      0\n",
       "АТС1                               0\n",
       "АТС2                              67\n",
       "АТС3                              67\n",
       "АТС4                             145\n",
       "АТС5                             223\n",
       "Ephmra1                            0\n",
       "Ephmra2                            0\n",
       "Ephmra3                            0\n",
       "Ephmra4                          493\n",
       "Год                                0\n",
       "Месяц                              0\n",
       "Объем1                             0\n",
       "Объем2                             0\n",
       "Объем3                             0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#проверим: пропущенных значений не осталось\n",
    "df1.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "f3677631-b8b3-40fb-9cd6-6bcf82e13f86",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Тип товара</th>\n",
       "      <th>Полное наименование</th>\n",
       "      <th>МНН</th>\n",
       "      <th>Лекарственная форма</th>\n",
       "      <th>Бренд</th>\n",
       "      <th>Фирма_производитель</th>\n",
       "      <th>Корпорация</th>\n",
       "      <th>Фармакотерапевтическая группа</th>\n",
       "      <th>АТС1</th>\n",
       "      <th>АТС2</th>\n",
       "      <th>...</th>\n",
       "      <th>АТС5</th>\n",
       "      <th>Ephmra1</th>\n",
       "      <th>Ephmra2</th>\n",
       "      <th>Ephmra3</th>\n",
       "      <th>Ephmra4</th>\n",
       "      <th>Год</th>\n",
       "      <th>Месяц</th>\n",
       "      <th>Объем1</th>\n",
       "      <th>Объем2</th>\n",
       "      <th>Объем3</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>АЛЕМТУЗУМАБ (L04AA34)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021</td>\n",
       "      <td>12</td>\n",
       "      <td>174317593</td>\n",
       "      <td>470</td>\n",
       "      <td>174317593</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>АЛЕМТУЗУМАБ (L04AA34)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>8</td>\n",
       "      <td>18729715</td>\n",
       "      <td>50</td>\n",
       "      <td>18729715</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>АЛЕМТУЗУМАБ (L04AA34)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019</td>\n",
       "      <td>9</td>\n",
       "      <td>24879249</td>\n",
       "      <td>50</td>\n",
       "      <td>24879249</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>АЛЕМТУЗУМАБ (L04AA34)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018</td>\n",
       "      <td>12</td>\n",
       "      <td>31115786</td>\n",
       "      <td>104</td>\n",
       "      <td>31115786</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>АЛЕМТУЗУМАБ (L04AA34)</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023</td>\n",
       "      <td>7</td>\n",
       "      <td>84412416</td>\n",
       "      <td>315</td>\n",
       "      <td>84412416</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3305</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ТЕТРАКОЗАКТИД</td>\n",
       "      <td>СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>СИНАКТЕН</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>АКТГ</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...</td>\n",
       "      <td>...</td>\n",
       "      <td>ТЕТРАКОЗАКТИД (H01AA02)</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)</td>\n",
       "      <td>КОРТИКОТРОПИН (H01A)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, БЕТА (L03B2)</td>\n",
       "      <td>2021</td>\n",
       "      <td>12</td>\n",
       "      <td>710</td>\n",
       "      <td>1</td>\n",
       "      <td>478</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3306</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ТЕТРАКОЗАКТИД</td>\n",
       "      <td>СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>СИНАКТЕН</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>АКТГ</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...</td>\n",
       "      <td>...</td>\n",
       "      <td>ТЕТРАКОЗАКТИД (H01AA02)</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)</td>\n",
       "      <td>КОРТИКОТРОПИН (H01A)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, БЕТА (L03B2)</td>\n",
       "      <td>2019</td>\n",
       "      <td>8</td>\n",
       "      <td>19383</td>\n",
       "      <td>32</td>\n",
       "      <td>15412</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3307</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ТЕТРАКОЗАКТИД</td>\n",
       "      <td>СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>СИНАКТЕН</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>АКТГ</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...</td>\n",
       "      <td>...</td>\n",
       "      <td>ТЕТРАКОЗАКТИД (H01AA02)</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)</td>\n",
       "      <td>КОРТИКОТРОПИН (H01A)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, БЕТА (L03B2)</td>\n",
       "      <td>2019</td>\n",
       "      <td>5</td>\n",
       "      <td>14686</td>\n",
       "      <td>30</td>\n",
       "      <td>12969</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3308</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ТЕТРАКОЗАКТИД</td>\n",
       "      <td>СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>СИНАКТЕН</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>АКТГ</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...</td>\n",
       "      <td>...</td>\n",
       "      <td>ТЕТРАКОЗАКТИД (H01AA02)</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)</td>\n",
       "      <td>КОРТИКОТРОПИН (H01A)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, БЕТА (L03B2)</td>\n",
       "      <td>2023</td>\n",
       "      <td>8</td>\n",
       "      <td>40700</td>\n",
       "      <td>20</td>\n",
       "      <td>40700</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3309</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10</td>\n",
       "      <td>ТЕТРАКОЗАКТИД</td>\n",
       "      <td>СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>СИНАКТЕН</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>NOVARTIS INTERNATIONAL AG</td>\n",
       "      <td>АКТГ</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...</td>\n",
       "      <td>...</td>\n",
       "      <td>ТЕТРАКОЗАКТИД (H01AA02)</td>\n",
       "      <td>ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...</td>\n",
       "      <td>ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)</td>\n",
       "      <td>КОРТИКОТРОПИН (H01A)</td>\n",
       "      <td>ИНТЕРФЕРОНЫ, БЕТА (L03B2)</td>\n",
       "      <td>2019</td>\n",
       "      <td>7</td>\n",
       "      <td>31310</td>\n",
       "      <td>65</td>\n",
       "      <td>25882</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3310 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   Тип товара  \\\n",
       "0     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "1     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "2     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "4     ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "...                       ...   \n",
       "3305  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3306  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3307  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3308  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "3309  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "\n",
       "                                    Полное наименование            МНН  \\\n",
       "0     ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...    АЛЕМТУЗУМАБ   \n",
       "1     ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...    АЛЕМТУЗУМАБ   \n",
       "2     ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...    АЛЕМТУЗУМАБ   \n",
       "3     ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...    АЛЕМТУЗУМАБ   \n",
       "4     ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...    АЛЕМТУЗУМАБ   \n",
       "...                                                 ...            ...   \n",
       "3305     СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10  ТЕТРАКОЗАКТИД   \n",
       "3306     СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10  ТЕТРАКОЗАКТИД   \n",
       "3307     СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10  ТЕТРАКОЗАКТИД   \n",
       "3308     СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10  ТЕТРАКОЗАКТИД   \n",
       "3309     СИНАКТЕН ДЕПО СУСП Д/В/М ВВЕД 1 МГ/МЛ 1 МЛ №10  ТЕТРАКОЗАКТИД   \n",
       "\n",
       "                                    Лекарственная форма     Бренд  \\\n",
       "0     КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "1     КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "2     КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "3     КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "4     КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "...                                                 ...       ...   \n",
       "3305             СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  СИНАКТЕН   \n",
       "3306             СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  СИНАКТЕН   \n",
       "3307             СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  СИНАКТЕН   \n",
       "3308             СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  СИНАКТЕН   \n",
       "3309             СУСПЕНЗИЯ ДЛЯ ВНУТРИМЫШЕЧНОГО ВВЕДЕНИЯ  СИНАКТЕН   \n",
       "\n",
       "            Фирма_производитель                 Корпорация  \\\n",
       "0           GENZYME CORPORATION                  SANOFI SA   \n",
       "1           GENZYME CORPORATION                  SANOFI SA   \n",
       "2           GENZYME CORPORATION                  SANOFI SA   \n",
       "3           GENZYME CORPORATION                  SANOFI SA   \n",
       "4           GENZYME CORPORATION                  SANOFI SA   \n",
       "...                         ...                        ...   \n",
       "3305  NOVARTIS INTERNATIONAL AG  NOVARTIS INTERNATIONAL AG   \n",
       "3306  NOVARTIS INTERNATIONAL AG  NOVARTIS INTERNATIONAL AG   \n",
       "3307  NOVARTIS INTERNATIONAL AG  NOVARTIS INTERNATIONAL AG   \n",
       "3308  NOVARTIS INTERNATIONAL AG  NOVARTIS INTERNATIONAL AG   \n",
       "3309  NOVARTIS INTERNATIONAL AG  NOVARTIS INTERNATIONAL AG   \n",
       "\n",
       "     Фармакотерапевтическая группа  \\\n",
       "0     СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "1     СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "2     СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "3     СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "4     СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "...                            ...   \n",
       "3305                          АКТГ   \n",
       "3306                          АКТГ   \n",
       "3307                          АКТГ   \n",
       "3308                          АКТГ   \n",
       "3309                          АКТГ   \n",
       "\n",
       "                                                   АТС1  \\\n",
       "0     ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "1     ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "2     ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "3     ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "4     ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "...                                                 ...   \n",
       "3305  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3306  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3307  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3308  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3309  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "\n",
       "                                                   АТС2  ...  \\\n",
       "0                               ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "1                               ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "2                               ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "3                               ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "4                               ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "...                                                 ...  ...   \n",
       "3305  ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...  ...   \n",
       "3306  ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...  ...   \n",
       "3307  ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...  ...   \n",
       "3308  ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...  ...   \n",
       "3309  ГИПОТАЛАМО-ГИПОФИЗАРНЫЕ ГОРМОНЫ И ИХ АНАЛОГИ (...  ...   \n",
       "\n",
       "                         АТС5  \\\n",
       "0       АЛЕМТУЗУМАБ (L04AA34)   \n",
       "1       АЛЕМТУЗУМАБ (L04AA34)   \n",
       "2       АЛЕМТУЗУМАБ (L04AA34)   \n",
       "3       АЛЕМТУЗУМАБ (L04AA34)   \n",
       "4       АЛЕМТУЗУМАБ (L04AA34)   \n",
       "...                       ...   \n",
       "3305  ТЕТРАКОЗАКТИД (H01AA02)   \n",
       "3306  ТЕТРАКОЗАКТИД (H01AA02)   \n",
       "3307  ТЕТРАКОЗАКТИД (H01AA02)   \n",
       "3308  ТЕТРАКОЗАКТИД (H01AA02)   \n",
       "3309  ТЕТРАКОЗАКТИД (H01AA02)   \n",
       "\n",
       "                                                Ephmra1  \\\n",
       "0     ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "1     ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "2     ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "3     ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "4     ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "...                                                 ...   \n",
       "3305  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3306  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3307  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3308  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "3309  ГОРМОНАЛЬНЫЕ ПРЕПАРАТЫ ДЛЯ СИСТЕМНОГО ИСПОЛЬЗО...   \n",
       "\n",
       "                                    Ephmra2  \\\n",
       "0         ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "1         ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "2         ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "3         ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "4         ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "...                                     ...   \n",
       "3305  ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)   \n",
       "3306  ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)   \n",
       "3307  ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)   \n",
       "3308  ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)   \n",
       "3309  ГОРМОНЫ ГИПОФИЗА И ГИПОТАЛАМУСА (H01)   \n",
       "\n",
       "                                               Ephmra3  \\\n",
       "0     МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)   \n",
       "1     МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)   \n",
       "2     МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)   \n",
       "3     МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)   \n",
       "4     МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)   \n",
       "...                                                ...   \n",
       "3305                              КОРТИКОТРОПИН (H01A)   \n",
       "3306                              КОРТИКОТРОПИН (H01A)   \n",
       "3307                              КОРТИКОТРОПИН (H01A)   \n",
       "3308                              КОРТИКОТРОПИН (H01A)   \n",
       "3309                              КОРТИКОТРОПИН (H01A)   \n",
       "\n",
       "                        Ephmra4   Год Месяц     Объем1  Объем2     Объем3  \n",
       "0                           NaN  2021    12  174317593     470  174317593  \n",
       "1                           NaN  2020     8   18729715      50   18729715  \n",
       "2                           NaN  2019     9   24879249      50   24879249  \n",
       "3                           NaN  2018    12   31115786     104   31115786  \n",
       "4                           NaN  2023     7   84412416     315   84412416  \n",
       "...                         ...   ...   ...        ...     ...        ...  \n",
       "3305  ИНТЕРФЕРОНЫ, БЕТА (L03B2)  2021    12        710       1        478  \n",
       "3306  ИНТЕРФЕРОНЫ, БЕТА (L03B2)  2019     8      19383      32      15412  \n",
       "3307  ИНТЕРФЕРОНЫ, БЕТА (L03B2)  2019     5      14686      30      12969  \n",
       "3308  ИНТЕРФЕРОНЫ, БЕТА (L03B2)  2023     8      40700      20      40700  \n",
       "3309  ИНТЕРФЕРОНЫ, БЕТА (L03B2)  2019     7      31310      65      25882  \n",
       "\n",
       "[3310 rows x 22 columns]"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# поскольку пропущеные значения только в текстовых столбцах, которые не сильно необходимы для дальнейшего анализа, то\n",
    "# Заполним пропуски значением из предыдущей строки\n",
    "df = df.ffill()\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "99514aca-09a6-4f44-9334-e44602a1b5a5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Год_n</th>\n",
       "      <th>Месяц_n</th>\n",
       "      <th>Объем1_n</th>\n",
       "      <th>Объем2_n</th>\n",
       "      <th>Объем3_n</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>0.997336</td>\n",
       "      <td>-0.995093</td>\n",
       "      <td>1.182776</td>\n",
       "      <td>-0.291226</td>\n",
       "      <td>1.184508</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>-0.163481</td>\n",
       "      <td>-0.995093</td>\n",
       "      <td>1.897533</td>\n",
       "      <td>-0.270282</td>\n",
       "      <td>1.898903</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>-1.324298</td>\n",
       "      <td>1.065762</td>\n",
       "      <td>0.082127</td>\n",
       "      <td>-0.280843</td>\n",
       "      <td>0.084417</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>0.416928</td>\n",
       "      <td>-0.700685</td>\n",
       "      <td>1.591147</td>\n",
       "      <td>-0.279241</td>\n",
       "      <td>1.592609</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>-0.743890</td>\n",
       "      <td>-0.406278</td>\n",
       "      <td>-0.152407</td>\n",
       "      <td>-0.217712</td>\n",
       "      <td>-0.149998</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>-0.743890</td>\n",
       "      <td>-0.700685</td>\n",
       "      <td>-0.122835</td>\n",
       "      <td>-0.204540</td>\n",
       "      <td>-0.120441</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>-0.163481</td>\n",
       "      <td>-0.700685</td>\n",
       "      <td>-0.179953</td>\n",
       "      <td>-0.277402</td>\n",
       "      <td>-0.177530</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>0.416928</td>\n",
       "      <td>-0.111870</td>\n",
       "      <td>2.021980</td>\n",
       "      <td>-0.150131</td>\n",
       "      <td>2.023286</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>0.416928</td>\n",
       "      <td>-1.583909</td>\n",
       "      <td>1.186784</td>\n",
       "      <td>-0.216822</td>\n",
       "      <td>1.188514</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>0.416928</td>\n",
       "      <td>-1.289501</td>\n",
       "      <td>-0.167979</td>\n",
       "      <td>0.484470</td>\n",
       "      <td>-0.165562</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       Год_n   Месяц_n  Объем1_n  Объем2_n  Объем3_n\n",
       "5   0.997336 -0.995093  1.182776 -0.291226  1.184508\n",
       "8  -0.163481 -0.995093  1.897533 -0.270282  1.898903\n",
       "16 -1.324298  1.065762  0.082127 -0.280843  0.084417\n",
       "21  0.416928 -0.700685  1.591147 -0.279241  1.592609\n",
       "71 -0.743890 -0.406278 -0.152407 -0.217712 -0.149998\n",
       "72 -0.743890 -0.700685 -0.122835 -0.204540 -0.120441\n",
       "76 -0.163481 -0.700685 -0.179953 -0.277402 -0.177530\n",
       "80  0.416928 -0.111870  2.021980 -0.150131  2.023286\n",
       "81  0.416928 -1.583909  1.186784 -0.216822  1.188514\n",
       "90  0.416928 -1.289501 -0.167979  0.484470 -0.165562"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Работа с выбросами \n",
    "#нормируем значения\n",
    "df1_num = df1.select_dtypes('int64')\n",
    "df1_std = pd.DataFrame()\n",
    "for col in df1_num.columns:\n",
    "    n = df1_num[col].mean()\n",
    "    s = df1_num[col].std()\n",
    "    df1_std[col + '_n'] = (df1_num[col] - n) / s\n",
    "df1_std.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "85c49acc-9e54-46aa-849a-94ed6ab58e27",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\todie\\AppData\\Local\\Temp\\ipykernel_13956\\1967219460.py:4: UserWarning: set_ticklabels() should only be used with a fixed number of ticks, i.e. after set_ticks() or using a FixedLocator.\n",
      "  ax.set_xticklabels(df1_std.columns)\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2000x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# визуализируем ящик с усами, чтобы оценить количество выбросов\n",
    "fig = plt.figure(figsize =(20,5))\n",
    "ax = fig.add_axes([0, 0, 1, 1])\n",
    "ax.set_xticklabels(df1_std.columns)\n",
    "\n",
    "data = []\n",
    "for col in df1_std.columns:\n",
    "    data.append(df1_std[col])\n",
    "\n",
    "bp = ax.boxplot(data, widths=0.5)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "f1f940a9-9559-40fe-98b2-cce853fda8db",
   "metadata": {},
   "outputs": [],
   "source": [
    "# для каждого столбца, кроме столбцов год и месяц пропишем цикл, в котором значениям, выходящим за интерквартилный размах будет присваиваться NaN\n",
    "for x in ['Объем1']:\n",
    "    q75,q25 = np.percentile(df1.loc[:,x],[75,25])\n",
    "    intr_qr = q75-q25\n",
    "\n",
    "    max = q75+(1.5*intr_qr)\n",
    "    min = q25-(1.5*intr_qr)\n",
    "\n",
    "    df1.loc[df1[x] < min,x] = np.nan\n",
    "    df1.loc[df1[x] > max,x] = np.nan\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "e84a90a8-0275-438e-af04-f6934e5ef3ce",
   "metadata": {},
   "outputs": [],
   "source": [
    "for x in ['Объем2']:\n",
    "    q75,q25 = np.percentile(df1.loc[:,x],[75,25])\n",
    "    intr_qr = q75-q25\n",
    "\n",
    "    max = q75+(1.5*intr_qr)\n",
    "    min = q25-(1.5*intr_qr)\n",
    "\n",
    "    df1.loc[df1[x] < min,x] = np.nan\n",
    "    df1.loc[df1[x] > max,x] = np.nan"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "57892e5f-b293-4201-9356-a430c2b3d8db",
   "metadata": {},
   "outputs": [],
   "source": [
    "for x in ['Объем3']:\n",
    "    q75,q25 = np.percentile(df1.loc[:,x],[75,25])\n",
    "    intr_qr = q75-q25\n",
    "\n",
    "    max = q75+(1.5*intr_qr)\n",
    "    min = q25-(1.5*intr_qr)\n",
    "\n",
    "    df1.loc[df1[x] < min,x] = np.nan\n",
    "    df1.loc[df1[x] > max,x] = np.nan"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "65c36967-99bf-42c9-8fc9-c1c4cb077096",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Тип товара                         0\n",
       "Полное наименование                0\n",
       "МНН                                0\n",
       "Лекарственная форма                0\n",
       "Бренд                              0\n",
       "Фирма_производитель                0\n",
       "Корпорация                         0\n",
       "Фармакотерапевтическая группа      0\n",
       "АТС1                               0\n",
       "АТС2                              67\n",
       "АТС3                              67\n",
       "АТС4                             145\n",
       "АТС5                             223\n",
       "Ephmra1                            0\n",
       "Ephmra2                            0\n",
       "Ephmra3                            0\n",
       "Ephmra4                          493\n",
       "Год                                0\n",
       "Месяц                              0\n",
       "Объем1                           162\n",
       "Объем2                           105\n",
       "Объем3                           162\n",
       "dtype: int64"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# но теперь появились нулевые значения, с которым проведём аналогичную работу\n",
    "df1.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "d514b81a-ac54-474f-86dc-960a4aac05e5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Объем1</th>\n",
       "      <th>Объем2</th>\n",
       "      <th>Объем3</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>1.680293e+06</td>\n",
       "      <td>1451.000000</td>\n",
       "      <td>1.514144e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>1.098529e+07</td>\n",
       "      <td>2157.000000</td>\n",
       "      <td>1.092749e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>7.987144e+06</td>\n",
       "      <td>1801.000000</td>\n",
       "      <td>7.916028e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>3.047094e+06</td>\n",
       "      <td>1855.000000</td>\n",
       "      <td>2.718345e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>3.503465e+07</td>\n",
       "      <td>3929.000000</td>\n",
       "      <td>3.503465e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3258</th>\n",
       "      <td>2.073421e+07</td>\n",
       "      <td>16023.000000</td>\n",
       "      <td>1.852207e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3262</th>\n",
       "      <td>8.924070e+06</td>\n",
       "      <td>5253.824219</td>\n",
       "      <td>8.209261e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3264</th>\n",
       "      <td>8.924070e+06</td>\n",
       "      <td>5253.824219</td>\n",
       "      <td>8.209261e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3267</th>\n",
       "      <td>8.924070e+06</td>\n",
       "      <td>5253.824219</td>\n",
       "      <td>8.209261e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3287</th>\n",
       "      <td>2.544243e+07</td>\n",
       "      <td>13097.000000</td>\n",
       "      <td>2.231843e+07</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1129 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            Объем1        Объем2        Объем3\n",
       "5     1.680293e+06   1451.000000  1.514144e+06\n",
       "8     1.098529e+07   2157.000000  1.092749e+07\n",
       "16    7.987144e+06   1801.000000  7.916028e+06\n",
       "21    3.047094e+06   1855.000000  2.718345e+06\n",
       "71    3.503465e+07   3929.000000  3.503465e+07\n",
       "...            ...           ...           ...\n",
       "3258  2.073421e+07  16023.000000  1.852207e+07\n",
       "3262  8.924070e+06   5253.824219  8.209261e+06\n",
       "3264  8.924070e+06   5253.824219  8.209261e+06\n",
       "3267  8.924070e+06   5253.824219  8.209261e+06\n",
       "3287  2.544243e+07  13097.000000  2.231843e+07\n",
       "\n",
       "[1129 rows x 3 columns]"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#заполняем образовавшиеся пропуски\n",
    "df_num3 = df1.select_dtypes('float64')\n",
    "imputer = KNNImputer(n_neighbors=5, weights='uniform') #создаем импьютер\n",
    "imputer.fit(df_num3)\n",
    "df_num3 = pd.DataFrame(imputer.transform(df_num3), index=df_num3.index, columns=df_num3.columns) #заполняем недостающие значения\n",
    "df_num3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "c73e5a5a-7831-4c83-9053-a5e9019ef214",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\todie\\AppData\\Local\\Temp\\ipykernel_13956\\205155323.py:2: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  df1['Объем1']=df_num3['Объем1']\n",
      "C:\\Users\\todie\\AppData\\Local\\Temp\\ipykernel_13956\\205155323.py:3: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  df1['Объем2']=df_num3['Объем2']\n",
      "C:\\Users\\todie\\AppData\\Local\\Temp\\ipykernel_13956\\205155323.py:4: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  df1['Объем3']=df_num3['Объем3']\n"
     ]
    }
   ],
   "source": [
    "#перезапишем в рабочий датафейм\n",
    "df1['Объем1']=df_num3['Объем1']\n",
    "df1['Объем2']=df_num3['Объем2']\n",
    "df1['Объем3']=df_num3['Объем3']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "36a03844-401b-4586-8e0c-9dcd8f07adaa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Тип товара                         0\n",
       "Полное наименование                0\n",
       "МНН                                0\n",
       "Лекарственная форма                0\n",
       "Бренд                              0\n",
       "Фирма_производитель                0\n",
       "Корпорация                         0\n",
       "Фармакотерапевтическая группа      0\n",
       "АТС1                               0\n",
       "АТС2                              67\n",
       "АТС3                              67\n",
       "АТС4                             145\n",
       "АТС5                             223\n",
       "Ephmra1                            0\n",
       "Ephmra2                            0\n",
       "Ephmra3                            0\n",
       "Ephmra4                          493\n",
       "Год                                0\n",
       "Месяц                              0\n",
       "Объем1                             0\n",
       "Объем2                             0\n",
       "Объем3                             0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#проверка: нулевых значений больше нет (Цена в это число пока не должна входить, т к она создается в следующей строке)\n",
    "df1.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "3d987ac1-02dd-4fdf-9c75-02188b36a01d",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\todie\\AppData\\Local\\Temp\\ipykernel_13956\\3746418277.py:2: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  df1['Цена'] = df1['Объем3']/df1['Объем2']\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Тип товара</th>\n",
       "      <th>Полное наименование</th>\n",
       "      <th>МНН</th>\n",
       "      <th>Лекарственная форма</th>\n",
       "      <th>Бренд</th>\n",
       "      <th>Фирма_производитель</th>\n",
       "      <th>Корпорация</th>\n",
       "      <th>Фармакотерапевтическая группа</th>\n",
       "      <th>АТС1</th>\n",
       "      <th>АТС2</th>\n",
       "      <th>...</th>\n",
       "      <th>Ephmra1</th>\n",
       "      <th>Ephmra2</th>\n",
       "      <th>Ephmra3</th>\n",
       "      <th>Ephmra4</th>\n",
       "      <th>Год</th>\n",
       "      <th>Месяц</th>\n",
       "      <th>Объем1</th>\n",
       "      <th>Объем2</th>\n",
       "      <th>Объем3</th>\n",
       "      <th>Цена</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022</td>\n",
       "      <td>3</td>\n",
       "      <td>1680293.4</td>\n",
       "      <td>1451.0</td>\n",
       "      <td>1514144.0</td>\n",
       "      <td>1043.517574</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>3</td>\n",
       "      <td>10985287.0</td>\n",
       "      <td>2157.0</td>\n",
       "      <td>10927490.0</td>\n",
       "      <td>5066.059342</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018</td>\n",
       "      <td>10</td>\n",
       "      <td>7987143.8</td>\n",
       "      <td>1801.0</td>\n",
       "      <td>7916028.2</td>\n",
       "      <td>4395.351582</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...</td>\n",
       "      <td>АЛЕМТУЗУМАБ</td>\n",
       "      <td>КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ</td>\n",
       "      <td>ЛЕМТРАДА</td>\n",
       "      <td>GENZYME CORPORATION</td>\n",
       "      <td>SANOFI SA</td>\n",
       "      <td>СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОДЕПРЕССАНТЫ (L04)</td>\n",
       "      <td>...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)</td>\n",
       "      <td>МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021</td>\n",
       "      <td>4</td>\n",
       "      <td>3047093.6</td>\n",
       "      <td>1855.0</td>\n",
       "      <td>2718345.0</td>\n",
       "      <td>1465.415094</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ</td>\n",
       "      <td>ГЛАТИРАТ РАСТ Д/П/К ВВЕД 20 МГ/МЛ 1 МЛ №28</td>\n",
       "      <td>ГЛАТИРАМЕРА АЦЕТАТ</td>\n",
       "      <td>РАСТВОР ДЛЯ ПОДКОЖНОГО ВВЕДЕНИЯ</td>\n",
       "      <td>ГЛАТИРАТ</td>\n",
       "      <td>Р-ФАРМ АО</td>\n",
       "      <td>Р-ФАРМ АО</td>\n",
       "      <td>ИММУНОМОДУЛИРУЮЩЕЕ СРЕДСТВО</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...</td>\n",
       "      <td>ИММУНОМОДУЛЯТОРЫ (L03)</td>\n",
       "      <td>...</td>\n",
       "      <td>ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ (L03)</td>\n",
       "      <td>ИММУНОСТИМУЛЯТОРЫ ИСКЛЮЧАЯ ИНТЕРФЕРОНЫ (L03A)</td>\n",
       "      <td>ПРОЧИЕ ИММУНОСТИМУЛИРУЮЩИЕ АГЕНТЫ, ИСКЛЮЧАЯ ИН...</td>\n",
       "      <td>2019</td>\n",
       "      <td>5</td>\n",
       "      <td>35034648.0</td>\n",
       "      <td>3929.0</td>\n",
       "      <td>35034648.0</td>\n",
       "      <td>8916.937643</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 23 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                 Тип товара  \\\n",
       "5   ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "8   ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "16  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "21  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "71  ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ   \n",
       "\n",
       "                                  Полное наименование                 МНН  \\\n",
       "5   ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...         АЛЕМТУЗУМАБ   \n",
       "8   ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...         АЛЕМТУЗУМАБ   \n",
       "16  ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...         АЛЕМТУЗУМАБ   \n",
       "21  ЛЕМТРАДА КОНЦ-Т Д/ПРИГ-Я РАСТ Д/ИНФ 10 МГ/МЛ 1...         АЛЕМТУЗУМАБ   \n",
       "71         ГЛАТИРАТ РАСТ Д/П/К ВВЕД 20 МГ/МЛ 1 МЛ №28  ГЛАТИРАМЕРА АЦЕТАТ   \n",
       "\n",
       "                                  Лекарственная форма     Бренд  \\\n",
       "5   КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "8   КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "16  КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "21  КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ  ЛЕМТРАДА   \n",
       "71                    РАСТВОР ДЛЯ ПОДКОЖНОГО ВВЕДЕНИЯ  ГЛАТИРАТ   \n",
       "\n",
       "    Фирма_производитель Корпорация Фармакотерапевтическая группа  \\\n",
       "5   GENZYME CORPORATION  SANOFI SA  СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "8   GENZYME CORPORATION  SANOFI SA  СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "16  GENZYME CORPORATION  SANOFI SA  СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "21  GENZYME CORPORATION  SANOFI SA  СЕЛЕКТИВНЫЙ ИММУНОДЕПРЕССАНТ   \n",
       "71            Р-ФАРМ АО  Р-ФАРМ АО   ИММУНОМОДУЛИРУЮЩЕЕ СРЕДСТВО   \n",
       "\n",
       "                                                 АТС1  \\\n",
       "5   ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "8   ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "16  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "21  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "71  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ И ИММУНОМОДУЛЯТОРЫ...   \n",
       "\n",
       "                       АТС2  ...  \\\n",
       "5   ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "8   ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "16  ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "21  ИММУНОДЕПРЕССАНТЫ (L04)  ...   \n",
       "71   ИММУНОМОДУЛЯТОРЫ (L03)  ...   \n",
       "\n",
       "                                              Ephmra1  \\\n",
       "5   ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "8   ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "16  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "21  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "71  ПРОТИВООПУХОЛЕВЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СРЕДСТВ...   \n",
       "\n",
       "                              Ephmra2  \\\n",
       "5   ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "8   ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "16  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "21  ПРОТИВООПУХОЛЕВЫЕ ПРЕПАРАТЫ (L01)   \n",
       "71            ИММУНОСТИМУЛЯТОРЫ (L03)   \n",
       "\n",
       "                                             Ephmra3  \\\n",
       "5   МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)   \n",
       "8   МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)   \n",
       "16  МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)   \n",
       "21  МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВООПУХОЛЕВОЕ (L01G)   \n",
       "71     ИММУНОСТИМУЛЯТОРЫ ИСКЛЮЧАЯ ИНТЕРФЕРОНЫ (L03A)   \n",
       "\n",
       "                                              Ephmra4   Год Месяц      Объем1  \\\n",
       "5                                                 NaN  2022     3   1680293.4   \n",
       "8                                                 NaN  2020     3  10985287.0   \n",
       "16                                                NaN  2018    10   7987143.8   \n",
       "21                                                NaN  2021     4   3047093.6   \n",
       "71  ПРОЧИЕ ИММУНОСТИМУЛИРУЮЩИЕ АГЕНТЫ, ИСКЛЮЧАЯ ИН...  2019     5  35034648.0   \n",
       "\n",
       "    Объем2      Объем3         Цена  \n",
       "5   1451.0   1514144.0  1043.517574  \n",
       "8   2157.0  10927490.0  5066.059342  \n",
       "16  1801.0   7916028.2  4395.351582  \n",
       "21  1855.0   2718345.0  1465.415094  \n",
       "71  3929.0  35034648.0  8916.937643  \n",
       "\n",
       "[5 rows x 23 columns]"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Создадим новый столбец \"Цена\", чтобы узнать стоимость препаратов, для этого в столбеце делим строки с Объем (цена опт.-уп.розн.), рубли на Объем (розница), упак.\n",
    "df1['Цена'] = df1['Объем3']/df1['Объем2']\n",
    "df1.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "d409ae45-b193-4d9c-85ea-99cf160b478d",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\todie\\AppData\\Local\\Temp\\ipykernel_13956\\3186817436.py:13: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  df1.loc[:, 'Свыше_1500'] = check(df1['Цена'])\n"
     ]
    }
   ],
   "source": [
    "# для каждого ценнового сегмента создадим новую колонку, в которую будем записывать соотвествует ли числовое значение данному сегменту\n",
    "def check(col):\n",
    "  res = []\n",
    "  for i in col:\n",
    "    if i < 1500:\n",
    "      res.append('недостаток')\n",
    "    elif i < 5000:\n",
    "      res.append('входит')\n",
    "    else:\n",
    "      res.append('избыток')\n",
    "  return res\n",
    "\n",
    "df1.loc[:, 'Свыше_1500'] = check(df1['Цена'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "c9284176-ec2f-46f9-8ab9-d506099c485f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Свыше_1500\n",
       "недостаток    785\n",
       "входит        239\n",
       "избыток       105\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1['Свыше_1500'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "b2259d6c-34a8-4ea4-8b81-0268ad52e955",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\todie\\AppData\\Local\\Temp\\ipykernel_13956\\1192706221.py:12: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  df1.loc[:, 'размер_500до1500'] = check(df1['Цена'])\n",
      "C:\\Users\\todie\\AppData\\Local\\Temp\\ipykernel_13956\\1192706221.py:25: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  df1.loc[:, 'до_500'] = check(df1['Цена'])\n"
     ]
    }
   ],
   "source": [
    "def check(col):\n",
    "  res = []\n",
    "  for i in col:\n",
    "    if i < 500:\n",
    "      res.append('недостаток')\n",
    "    elif i < 1500:\n",
    "      res.append('входит')\n",
    "    else:\n",
    "      res.append('избыток')\n",
    "  return res\n",
    "\n",
    "df1.loc[:, 'размер_500до1500'] = check(df1['Цена'])\n",
    "\n",
    "def check(col):\n",
    "  res = []\n",
    "  for i in col:\n",
    "    if i < 1:\n",
    "      res.append('недостаток')\n",
    "    elif i < 500:\n",
    "      res.append('входит')\n",
    "    else:\n",
    "      res.append('избыток')\n",
    "  return res\n",
    "\n",
    "df1.loc[:, 'до_500'] = check(df1['Цена'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "95cf6d95-c219-45fc-ba95-73a3375a6a27",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "размер_500до1500\n",
       "входит        707\n",
       "избыток       344\n",
       "недостаток     78\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1['размер_500до1500'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "a6481193-2f7d-4b15-b409-816de14e019e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "до_500\n",
       "избыток    1051\n",
       "входит       78\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1['до_500'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "d5cf0164-4139-4a7c-80cb-6e96da6e7250",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Лекарственная форма:\n",
      "Лекарственная форма\n",
      "РАСТВОР ДЛЯ ПОДКОЖНОГО ВВЕДЕНИЯ                                             684\n",
      "РАСТВОР ДЛЯ ВНУТРИМЫШЕЧНОГО И ПОДКОЖНОГО ВВЕДЕНИЯ                           436\n",
      "РАСТВОР ДЛЯ ИНЪЕКЦИЙ                                                        305\n",
      "ЛИОФИЛИЗАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНЪЕКЦИЙ И МЕСТНОГО ПРИМЕНЕНИЯ    298\n",
      "КОНЦЕНТРАТ ДЛЯ ПРИГОТОВЛЕНИЯ РАСТВОРА ДЛЯ ИНФУЗИЙ                           269\n",
      "Name: count, dtype: int64\n",
      "\n",
      "\n",
      "Распределение Брендов по упоминанию:\n",
      "Бренд\n",
      "РЕАФЕРОН            491\n",
      "ЛАЙФФЕРОН           423\n",
      "АЛЬТЕВИР            280\n",
      "АЛЬФАРОНА           174\n",
      "НЕОВИР              156\n",
      "НЕЙРОМИДИН          148\n",
      "КОПАКСОН            146\n",
      "АКСАМОН             144\n",
      "ИПИГРИКС            144\n",
      "РЕБИФ               132\n",
      "ПЛЕГРИДИ             90\n",
      "ИНФИБЕТА             81\n",
      "ИНТЕРФЕРОН           75\n",
      "ОКРЕВУС              67\n",
      "БИННОФЕРОН АЛЬФА     67\n",
      "ТИМЕКСОН             67\n",
      "ИНТРОН               66\n",
      "КЛАДРИБИН            59\n",
      "ЛЕЙКЛАДИН            59\n",
      "ТИЗАБРИ              57\n",
      "ЛЕМТРАДА             52\n",
      "ИНТЕРФЕРАЛЬ          44\n",
      "СИННОВЕКС            42\n",
      "БЕТАФЕРОН            40\n",
      "ТЕБЕРИФ              40\n",
      "ГЛАТИРАТ             37\n",
      "ИНТЕРАЛЬ             26\n",
      "ГЕНФАКСОН            24\n",
      "РЕАЛЬДИРОН           22\n",
      "ЭБЕРОН               17\n",
      "СИНАКТЕН             16\n",
      "АКСОГЛАТИРАН ФС      15\n",
      "РОНБЕТАЛ              9\n",
      "Name: count, dtype: int64\n",
      "\n",
      "\n",
      "Распределение по МНН:\n",
      "МНН\n",
      "ИНТЕРФЕРОН АЛЬФА-2B                  1421\n",
      "ИПИДАКРИН                             436\n",
      "ГЛАТИРАМЕРА АЦЕТАТ                    265\n",
      "ИНТЕРФЕРОН БЕТА-1A                    238\n",
      "ИНТЕРФЕРОН АЛЬФА-2                    197\n",
      "ИНТЕРФЕРОН БЕТА-1B                    197\n",
      "ОКСОДИГИДРОАКРИДИНИЛАЦЕТАТ НАТРИЯ     156\n",
      "КЛАДРИБИН                             118\n",
      "ПЭГИНТЕРФЕРОН БЕТА-1А                  90\n",
      "ОКРЕЛИЗУМАБ                            67\n",
      "НАТАЛИЗУМАБ                            57\n",
      "АЛЕМТУЗУМАБ                            52\n",
      "ТЕТРАКОЗАКТИД                          16\n",
      "Name: count, dtype: int64\n",
      "\n",
      "\n",
      "Топ годов:\n",
      "Год\n",
      "2019    634\n",
      "2018    632\n",
      "2020    539\n",
      "2021    538\n",
      "2022    503\n",
      "Name: count, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "#Исследовательский анализ данных\n",
    "def analyze_data(df1):\n",
    "    print(\"\\n Анализ данных \\n\")\n",
    "# Анализ по Лекарственной формы\n",
    "print(\"Лекарственная форма:\")\n",
    "print(df['Лекарственная форма'].value_counts().head())\n",
    "print(\"\\n\")\n",
    "# Анализ по Брендам\n",
    "print(\"Распределение Брендов по упоминанию:\")\n",
    "print(df['Бренд'].value_counts())\n",
    "print(\"\\n\")\n",
    "\n",
    "# Анализ по МНН\n",
    "print(\"Распределение по МНН:\")\n",
    "print(df['МНН'].value_counts())\n",
    "print(\"\\n\")\n",
    "\n",
    "# Анализ по годам\n",
    "print(\"Топ годов:\")\n",
    "print(df['Год'].value_counts().head())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "fb5e0fc5-f3f9-4155-b16c-c166185b2422",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 960x800 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#Оформление дашборда\n",
    "#посмотрим на корреляцию принаков между собой, возможно это поможет в дальнейшем анализе\n",
    "plt.figure(figsize=(12,10), dpi=80)\n",
    "sns.heatmap(df1_num.corr(method='spearman'), xticklabels=df1_num.corr(method='spearman').columns, yticklabels=df1_num.corr(method='spearman').columns, cmap='coolwarm', center=0, annot=True)\n",
    "plt.xticks(fontsize=12)\n",
    "plt.yticks(fontsize=12)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "927041d6-a861-4085-95ca-82d9ee699b4b",
   "metadata": {},
   "outputs": [],
   "source": [
    "def create_visualizations(df1):\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "50a4a429-ba34-4723-9947-bc63eede76ca",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "    # График 1: Распределение Объема (розница), упак. по  МНН\n",
    "    plt.figure(figsize=(10, 6))\n",
    "    sns.countplot(data=df1, x='МНН')\n",
    "    plt.xticks(rotation=45)\n",
    "    plt.title('Объем2 of МНН')\n",
    "    plt.tight_layout()\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "f28f0beb-cfe6-4294-a1b0-b565db77555e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# График 2: Распределение упоминания Объем (цена опт.-уп.розн.), рубли по годам\n",
    "plt.figure(figsize=(10, 6))\n",
    "sns.countplot(data=df1, x='Год')\n",
    "plt.xticks(rotation=45)\n",
    "plt.title('Объем1, by Год')\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "d0d92fd5-7682-4b93-aaf3-19808ebf15f7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x1000 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# График 3: Общая ависимость упоминания МНН\n",
    "plt.figure(figsize=(12, 10))\n",
    "df1['МНН'].value_counts().plot(kind='pie', autopct='%1.1f%%')\n",
    "plt.title('Distribution of МНН')\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "id": "f7e741e8-8574-4910-bcfc-5eef599043d8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'total_rows': 1129, 'total_columns': 26, 'missing_values': {'Тип товара': 0, 'Полное наименование': 0, 'МНН': 0, 'Лекарственная форма': 0, 'Бренд': 0, 'Фирма_производитель': 0, 'Корпорация': 0, 'Фармакотерапевтическая группа': 0, 'АТС1': 0, 'АТС2': 67, 'АТС3': 67, 'АТС4': 145, 'АТС5': 223, 'Ephmra1': 0, 'Ephmra2': 0, 'Ephmra3': 0, 'Ephmra4': 493, 'Год': 0, 'Месяц': 0, 'Объем1': 0, 'Объем2': 0, 'Объем3': 0, 'Цена': 0, 'Свыше_1500': 0, 'размер_500до1500': 0, 'до_500': 0}, 'duplicates': 0, 'completeness': {'Тип товара': 1.0, 'Полное наименование': 1.0, 'МНН': 1.0, 'Лекарственная форма': 1.0, 'Бренд': 1.0, 'Фирма_производитель': 1.0, 'Корпорация': 1.0, 'Фармакотерапевтическая группа': 1.0, 'АТС1': 1.0, 'АТС2': 0.9406554472984943, 'АТС3': 0.9406554472984943, 'АТС4': 0.8715677590788309, 'АТС5': 0.8024800708591674, 'Ephmra1': 1.0, 'Ephmra2': 1.0, 'Ephmra3': 1.0, 'Ephmra4': 0.5633303808680248, 'Год': 1.0, 'Месяц': 1.0, 'Объем1': 1.0, 'Объем2': 1.0, 'Объем3': 1.0, 'Цена': 1.0, 'Свыше_1500': 1.0, 'размер_500до1500': 1.0, 'до_500': 1.0}, 'unique_values': {'Тип товара': 1, 'Полное наименование': 58, 'МНН': 12, 'Лекарственная форма': 12, 'Бренд': 23, 'Фирма_производитель': 21, 'Корпорация': 21, 'Фармакотерапевтическая группа': 9, 'АТС1': 3, 'АТС2': 5, 'АТС3': 5, 'АТС4': 6, 'АТС5': 11, 'Ephmra1': 2, 'Ephmra2': 4, 'Ephmra3': 7, 'Ephmra4': 4, 'Год': 6, 'Месяц': 12, 'Объем1': 1044, 'Объем2': 993, 'Объем3': 1044, 'Цена': 1051, 'Свыше_1500': 3, 'размер_500до1500': 3, 'до_500': 2}}\n"
     ]
    }
   ],
   "source": [
    "def calculate_quality_metrics(df1):\n",
    "    # Определите словарь metrics в функции\n",
    "    metrics = {\n",
    "        'total_rows': len(df1),\n",
    "        'total_columns': len(df1.columns),\n",
    "        'missing_values': df1.isnull().sum().to_dict(),\n",
    "        'duplicates': len(df1) - len(df1.drop_duplicates()),\n",
    "        'completeness': (1 - df1.isnull().sum() / len(df1)).to_dict(),\n",
    "        'unique_values': df1.nunique().to_dict()\n",
    "    }\n",
    "    return metrics\n",
    "\n",
    "metrics = calculate_quality_metrics(df1)\n",
    "print(metrics)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "9d7207b1-7c99-4fd7-8163-b4c96d1ae6f3",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Сохраняем измененный файл"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "fa7599d6-2d06-49ab-b5af-53b4ce491717",
   "metadata": {},
   "outputs": [],
   "source": [
    "df1.to_csv('Desktop/Новая папка/clean_data.csv', sep=';', encoding='utf-8-sig')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "eaf41e75-b0e2-448e-bce3-dbb5ba67c6a0",
   "metadata": {},
   "outputs": [],
   "source": [
    "from csv import reader\n",
    "# Установить соединение с базой данных\n",
    "conn = sqlite3.connect('Desktop/Новая папка/clean_db.sqlite3')\n",
    "c = conn.cursor()\n",
    "\n",
    " # Создаем таблицу analytics\n",
    "c.execute( '''CREATE TABLE analy(\n",
    "id INTEGER PRIMARY KEY AUTOINCREMENT,\n",
    "Тип товара TEXT,\n",
    "Полное наименование TEXT,\n",
    "МНН TEXT,\n",
    "Лекарственная форма TEXT,\n",
    "Бренд TEXT,\n",
    "Фирма_производитель TEXT,\n",
    "Корпорация TEXT,\n",
    "Фармакотерапевтическая группа TEXT,\n",
    "АТС1 TEXT,\n",
    "АТС2 TEXT,\n",
    "АТС3 TEXT,\n",
    "АТС4 TEXT,\n",
    "АТС5 TEXT,\n",
    "Ephmra1 TEXT,\n",
    "Ephmra2 TEXT,\n",
    "Ephmra3 TEXT,\n",
    "Ephmra4 TEXT,\n",
    "Год INTEGER,\n",
    "Месяц INTEGER,\n",
    "Объем1 INTEGER,\n",
    "Объем2 INTEGER,\n",
    "Объем3 INTEGER,\n",
    "Cвыше_1500 TEXT,\n",
    "размер_500до1500 TEXT,\n",
    "до_500 TEXT,\n",
    "Цена TEXT)''')\n",
    "\n",
    "# Вставка данных в таблицу\n",
    "data = []\n",
    "\n",
    "with open('Desktop/Новая папка/clean_data.csv', encoding='utf-8') as f:\n",
    "    read = reader(f, delimiter=';')\n",
    "    read.__next__()\n",
    "    for line in read:\n",
    "        chunk = []\n",
    "        chunk.append(line[1])\n",
    "        chunk.append(line[2])\n",
    "        chunk.append(line[3])\n",
    "        chunk.append(line[4])\n",
    "        chunk.append(line[5])\n",
    "        chunk.append(line[6])\n",
    "        chunk.append(line[7])\n",
    "        chunk.append(line[8])\n",
    "        chunk.append(line[9])\n",
    "        chunk.append(line[10])\n",
    "        chunk.append(line[11])\n",
    "        chunk.append(line[12])\n",
    "        chunk.append(line[13])\n",
    "        chunk.append(line[14])\n",
    "        chunk.append(line[15])\n",
    "        chunk.append(line[16])\n",
    "        chunk.append(line[17])\n",
    "        chunk.append(int(line[18]))\n",
    "        chunk.append(float(line[19]))\n",
    "        chunk.append(float(line[20]))\n",
    "        chunk.append(float(line[21]))\n",
    "        chunk.append(float(line[22]))\n",
    "        chunk.append(line[23])\n",
    "        chunk.append(line[24])\n",
    "        chunk.append(line[25])\n",
    "        chunk.append(line[26])\n",
    "        data.append(chunk)\n",
    "\n",
    "with conn:\n",
    "    c.executemany(\n",
    "        '''\n",
    "        INSERT INTO analytics VALUES(null, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?)\n",
    "        ''',\n",
    "        data\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d2bec9e5-7cef-4d35-9447-9bd72066e31b",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
